Patent of Crestor expires on Apr 11, so authentic subsequent drugs are pouring into the market

Today (Apr 11), as patent of hyperlipidemia treatment Crestor (Rosuvastatin) expires, subsequent drug competition begins.

On Apr 11, according to the related industry, patent of Crestor expires, so authentic subsequent drugs pour. The number of generic drugs which completed registration in the insurance benefit list and whose release is available now, includes 122 items from 56 pharmaceutical ...